Ventana Medical Systems, Inc DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News, GMP

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Virtual Booth

Contact Supplier

European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

2 News #PharmaBuzz

media
2 News #PharmaBuzz

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

"Our culture of constant innovation fuels our vision: to empower our customers by providing the highest quality, most innovative cancer diagnostic solutions. We are passionate in our pursuit of diagnostic leadership because when we empower pathology professionals, we improve the outlook for patients. Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. Passionately pursuing their mission to improve the lives of all patients afflicted with cancer, the people of Ventana discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Ventana manufactures over 220 cancer tests with related instruments right here in southern Arizona for 80 countries, and most importantly, for 4 million people afflicted with cancer yearly around the world. Ventana products provide healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies. This pioneering company also offers premier workflow solutions to improve laboratory efficiency and preserve patient safety. Linking the most accurate diagnosis with the most targeted and relevant therapeutic is the essence of Personalized Healthcare. The value of the Personalized Healthcare approach is rooted in positive outcomes for the patient—saving lives and improving the quality of life. Ventana is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyze patient samples at the molecular level to help determine the best course of therapy for each individual patient. Ventana enables this with its global leadership as the number 1 Pharma Industry Partner of Choice in the development and commercialization of companion diagnostics for cancer patients. As a member of the Roche Group, drawing on powerful partnerships with world-class scientific institutions, there is no other company in the world in a better position to make this approach a reality."

International Sweetene...International Sweetener Colloquium

Not Confirmed

Not Confirmed

22-25 February, 2026

Championsgate, Florida
AAMAAM

Not Confirmed

Not Confirmed

23-25 February, 2026

Miami, Florida, U.S.A
Clinical Trial Supply ...Clinical Trial Supply Europe

Not Confirmed

Not Confirmed

24-25 February, 2026

Barcelona, Spain

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

Country

U.S.A

Address

1910 Innovation Park Dr. Tucson, AZ 85755

Telephone

+1 (520) 887-2155

enquiries@pharmacompass.com

Website

https://diagnostics.roche.com/global/en/products/product-category/anatomical-pathology.html

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

West Cancer Center & Research Institute partners with Roche Tissue Diagnostics

25 Sep 2019

// PR NEWSWIRE

Roche launches new VENTANA HER2 Dual ISH companion diagnostic test

23 Apr 2019

// PRESS RELEASE

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Company profile for Ventana Medical Systems, Inc